Coronary artery bypass grafting within 30 days after treatment of acute myocardial infarctions with angioplasty or fibrinolysis - a surgical substudy of DANAMI-2

By Kjaergard Henrik   Nielsen Per Hostrup   Andreasen Jan Jesper   Steinbrüchel Daniel   Andersen Lars Ib   Rasmussen Klaus   Andersen Henning Rud   Toftegaard Nielsen Torsten  

Scandinavian Cardiovascular Journal, Vol. 38, Iss. 3, 2004-06 ,pp. : 143-146

Informa Healthcare

Access to resources Recommend Favorite

Aquaporin-7 expression during coronary artery bypass grafting with Diazoxide

By Shalaby Ahmed   Mennander Ari   Rinne Timo   Oksala Niku   Aanismaa Riikka   Narkilahti Susanna   Paavonen Timo   Laurikka Jari   Tarkka Matti  

Scandinavian Cardiovascular Journal, Vol. 45, Iss. 6, 2011-12 ,pp. : 354-359

Informa Healthcare

Access to resources Recommend Favorite

Is coronary artery bypass grafting an acceptable alternative to myotomy for the treatment of myocardial bridging?

By Attaran Saina   Moscarelli Marco   Athanasiou Thanos   Anderson Jon  

Interactive CardioVascular and Thoracic Surgery, Vol. 16, Iss. 3, 2013-03 ,pp. : 347-349

Oxford University Press

Access to resources Recommend Favorite

Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting

By Koster A.   Spiess B.   Chew D.P.   Krabatsch T.   Tambeur L.   DeAnda A.   Hetzer R.   Kuppe H.   Smedira N.G.   Lincoff A.M.  

The American Journal of Cardiology, Vol. 93, Iss. 3, 2004-02 ,pp. : 356-359

Elsevier

Access to resources Recommend Favorite

Peripheral blood monocyte activation during coronary artery bypass grafting with or without cardiopulmonary bypass

By Wehlin Lena   Vedin Jenny   Vaage Jarle   Lundahl Joachim  

Scandinavian Cardiovascular Journal, Vol. 39, Iss. 1-2, 2005-04 ,pp. : 78-86

Informa Healthcare

Access to resources Recommend Favorite